We aimed to systematically examine literature on the prevalence of known modifiable and nonmodifiable risk factors for premature coronary heart disease (PCHD) in women compared with men.
Materials and Methods:
PubMed, CINAHL, Embase, and Web of Science databases were searched. Review protocol is registered in PROSPERO (CRD42020173216). Quality was assessed using the National Heart, Lung, and Blood Institute tool. Review Manager 5.3 was used for meta-analysis. Effect sizes were expressed as odds ratio (OR) and mean differences/standardized mean differences (SMD) with 95% confidence intervals (CIs) for categorical and continuous variables.
Results:
In this PCHD cohort (age <65 years), the mean age of presentation in women was 3 years older than men. Women had higher total cholesterol (SMD 0.11; 95% CI 0.00 to 0.23) and higher high-density lipoprotein cholesterol (SMD 0.49; 95% CI 0.29 to 0.69). Women were more likely to have hypertension (OR 1.51, 95% CI 1.42 to 1.60), diabetes mellitus (OR 1.78, 95% CI 1.55 to 2.04), obesity (OR 1.33, 95% CI 1.24 to 1.42), metabolic syndrome (OR 3.73, 95% CI 1.60 to 8.69), stroke (OR 1.63, 95% CI 1.51 to 1.77), peripheral vascular disorder (OR 1.67, 95% CI 1.43 to 1.96), and depression (OR 2.29, 95% CI 1.96 to 2.67). Women were less likely to be smokers (OR 0.60, 95% CI 0.55 to 0.66), have reported alcohol intake (OR 0.36, 95% CI 0.33 to 0.40), and reported use of illicit drug (OR 0.32, 95% CI 0.16 to 0.62).
Conclusions:
Risk factor profile in PCHD has a clear sex difference that supports early, aggressive, holistic, but sex-specific, approach to prevention.
Get full access to this article
View all access options for this article.
References
1.
RogerVL, GoAS, Lloyd-JonesDM, et al.Heart disease and stroke statistics—2011 update: A report from the American Heart Association. Circulation, 2011; 123(4):e18–e209; doi: 10.1161/CIR.0b013e3182009701
2.
YusufS, HawkenS, ÔunpuuS, et al.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet, 2004; 364(9438):937–952; doi: 10.1016/S0140-6736(04)17018-9
3.
Sanchis-GomarF, Perez-QuilisC, LeischikR, et al.Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med, 2016; 4(13):256; doi: 10.21037/atm.2016.06.33
4.
AchariV, ThakurA. Association of major modifiable risk factors among patients with coronary artery disease—A retrospective analysis. J Assoc Phys India, 2004; 52:103–108.
5.
SharmaM, GangulyNK. Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag, 2005; 1(3):217.
6.
GaoZ, ChenZ, SunA, et al.Gender differences in cardiovascular disease. Med Novel Technol Dev, 2019; 4:100025; doi: 10.1016/j.medntd.2019.100025
7.
AppelmanY, van RijnBB, MoniqueE, et al.Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis, 2015; 241(1):211–218; doi: 10.1016/j.atherosclerosis.2015.01.027
8.
GiovinoGA, MirzaSA, SametJM, et al.Tobacco use in 3 billion individuals from 16 countries: An analysis of nationally representative cross-sectional household surveys. Lancet, 2012; 380(9842):668–679; doi: 10.1016/S0140-6736(12)61085-X
9.
PathiranaMM, LassiZ, AliA, et al.Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta-analysis. Rev Endocr Metab Disord, 2021; 22(4):729–761; doi: 10.1007/s11154-020-09587-0
10.
AndraweeraP, DekkerG, ArstallM, et al.Complications of Pregnancy and Future Cardiovascular Risk. In: Encyclopedia of Cardiovascular Research and Medicine, vol 1. (VasanRS, SawyerDB. eds.) Elsevier, Inc.: Oxford; 2018; pp. 643–650.
11.
WengerNK. You've come a long way, baby: Cardiovascular health and disease in women: Problems and prospects. Circulation, 2004; 109(5):558–560; doi: 10.1161/01.CIR.0000117292.19349.D0
12.
MoscaL, Mochari-GreenbergerH, DolorRJ, et al.Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circulation Cardiovasc Qual Outcomes, 2010; 3(2):120–127; doi: 10.1161/CIRCOUTCOMES.109.915538
13.
MoscaL, LinfanteAH, BenjaminEJ, et al.National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation, 2005; 111(4):499–510; doi: 10.1161/01.CIR.0000154568.43333.82
14.
ValenteS, LazzeriC, ChiostriM, et al.Gender-related difference in ST-elevation myocardial infarction treated with primary angioplasty: A single-centre 6-year registry. Eur J Prev Cardiol, 2012; 19(2):233–240; doi: 10.1177/1741826711400511
15.
FutemaM, CooperJA, CharakidaM, et al.Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC). Atherosclerosis, 2017; 260:47–55; doi: 10.1016/j.atherosclerosis.2017.03.007
16.
JiangL, Benito-VicenteA, TangL, et al.Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene. Atherosclerosis, 2017; 263:163–170; doi: 10.1016/j.atherosclerosis.2017.06.014
17.
PaavolaT, BergmannU, KuusistoS, et al.Distinct fatty acid compositions of HDL phospholipids are characteristic of metabolic syndrome and premature coronary heart disease—Family study. Int J Mol Sci, 2021; 22(9):4908; doi: 10.3390/ijms22094908
18.
PrasongsukarnK, DechkhajornW, BenjathummarakS, et al.TRPM2, PDLIM5, BCL3, CD14, GBA genes as feasible markers for premature coronary heart disease risk. Front Genet, 2021; 12:598296; doi: 10.3389/fgene.2021.598296
19.
PaavolaT, Kangas-KontioT, SalonurmiT, et al.Plasma levels of antibodies against oxidized LDL are inherited but not associated with HDL-cholesterol level in families with early coronary heart disease. Atherosclerosis, 2012; 224(1):123–128; doi: 10.1016/j.atherosclerosis.2012.06.056
20.
FloridoR, ZhaoD, NdumeleCE, et al.Physical activity, parental history of premature coronary heart disease, and incident atherosclerotic cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J Am Heart Assoc, 2016; 5(9):e003505; doi: 10.1161/JAHA.116.003505
21.
LariflaL, BeaneyKE, FoucanL, et al.Influence of genetic risk factors on coronary heart disease occurrence in Afro-Caribbeans. Can J Cardiol, 2016; 32(8):978–985; doi: 10.1016/j.cjca.2016.01.004
22.
PechlivanisS, LehmannN, HoffmannP, et al.Risk prediction for coronary heart disease by a genetic risk score-results from the Heinz Nixdorf Recall study. BMC Med Genet, 2020; 21(1):178; doi: 10.1186/s12881-020-01113-y
23.
HamadR, PenkoJ, KaziDS, et al.Association of low socioeconomic status with premature coronary heart disease in US adults. JAMA Cardiol, 2020; 5(8):899–908; doi: 10.1001/jamacardio.2020.1458
24.
FiscellaK, TancrediD, FranksP. Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment. Am Heart J, 2009; 157(6):988–994; doi: 10.1016/j.ahj.2009.03.019
25.
Yepes-NuñezJ, UrrutiaG, Romero-GarciaM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Rev Esp Cardiol, 2021; 74(9):790–799; doi: 10.1016/j.rec.2021.07.010
26.
KhojaA, AndraweeraPH, LassiZS, et al.Risk factors for premature coronary artery disease (PCAD) in adults: A systematic review protocol. F1000Res, 2021; 10:1228; doi: 10.12688/f1000research.74926.1
27.
Study Quality Assessment Tools. National Heart, Lung, and Blood Institute. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools [Last accessed: May11, 2021].
28.
SabbagA, MatetzkyS, PorterA, et al.Sex differences in the management and 5-year outcome of young patients (<55 years) with acute coronary syndromes. Am J Med, 2017; 130(11):1324.e15–e22; doi: 10.1016/j.amjmed.2017.05.028
29.
BandyopadhyayD, ChakrabortyS, AmgaiB, et al.Acute myocardial infarction in the young-National Trend Analysis with gender-based difference in outcomes. Int J Cardiol, 2020; 301:21–28; doi: 10.1016/j.ijcard.2019.11.096
30.
BucholzEM, StraitKM, DreyerRP, et al.Editor's choice-sex differences in young patients with acute myocardial infarction: A VIRGO study analysis. Eur Heart J Acute Cardiovasc Care, 2017; 6(7):610–622; doi: 10.1177/2048872616661847
31.
ChoiJ, DaskalopoulouSS, ThanassoulisG, et al.Sex-and gender-related risk factor burden in patients with premature acute coronary syndrome. Can J Cardiol, 2014; 30(1):109–117; doi: 10.1016/j.cjca.2013.07.674
32.
O'BrienC, ValsdottirL, WasfyJH, et al.Comparison of 30-day readmission rates after hospitalization for acute myocardial infarction in men versus women. Am J Cardiol, 2017; 120(7):1070–1076; doi: 10.1016/j.amjcard.2017.06.046
33.
DavisM, DiamondJ, MontgomeryD, et al.Acute coronary syndrome in young women under 55 years of age: Clinical characteristics, treatment, and outcomes. Clin Res Cardiol, 2015; 104(8):648–655; doi: 10.1007/s00392-015-0827-2
34.
EgizianoG, AkhtariS, PiloteL, et al.Sex differences in young patients with acute myocardial infarction. Diabet Med, 2013; 30(3):e108–e114; doi: 10.1111/dme.12084
35.
JortveitJ, PrippAH, LangørgenJ, et al.Incidence, risk factors and outcome of young patients with myocardial infarction. Heart, 2020; 106(18):1420–1426; doi: 10.1136/heartjnl-2019-316067
36.
VikulovaDN, GrubisicM, ZhaoY, et al.Premature atherosclerotic cardiovascular disease: Trends in incidence, risk factors, and sex-related differences, 2000 to 2016. J Am Heart Assoc, 2019; 8(14):e012178; doi: 10.1161/JAHA.119.012178
37.
AbbasiSH, KassaianSE, SadeghianS, et al.Factors associated with depressive symptoms in young adults with coronary artery disease: Tehran Heart Center's premature coronary atherosclerosis cohort (THC-PAC) study. Iran J Psychiatry, 2016; 11(4):214.
38.
Hochner-CelnikierD, ManorO, GotzmanO, et al.Gender gap in coronary artery disease: Comparison of the extent, severity and risk factors in men and women aged 45–65 years. Cardiology, 2002; 97(1):18–23; doi: 10.1159/000047414
39.
LiuJ, ElbadawiA, ElgendyIY, et al.Age-stratified sex disparities in care and outcomes in patients with ST-elevation myocardial infarction. Am J Med, 2020; 133(11):1293–1301.e1; doi: 10.1016/j.amjmed.2020.03.059
40.
ShehabA, BhagavathulaAS, AlhabibKF, et al.Age-related sex differences in clinical presentation, management, and outcomes in ST-segment–elevation myocardial infarction: Pooled analysis of 15 532 patients from 7 Arabian Gulf Registries. J Am Heart Assoc, 2020; 9(4):e013880; doi: 10.1161/JAHA.119.013880
41.
IyengarS, GuptaR, RaviS, et al.Premature coronary artery disease in India: Coronary artery disease in the young (CADY) registry. Indian Heart J, 2017; 69(2):211–216; doi: 10.1016/j.ihj.2016.09.009
42.
CenarroA, ArtiedaM, CastilloS, et al.A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. J Med Genet, 2003; 40(3):163–168; doi: 10.1136/jmg.40.3.163
43.
FriedlanderY, SchwartzSM, DurstR, et al.SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction. Atherosclerosis, 2008; 196(2):896–904; doi: 10.1016/j.atherosclerosis.2007.02.006
44.
HopkinsPN, HuntSC, SchreinerPJ, et al.Lipoprotein (a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: Results from the NHLBI Family Heart Study. Atherosclerosis, 1998; 141(2):333–345; doi: 10.1016/S0021-9150(98)00174-9
45.
HopkinsPN, WuLL, HuntSC, et al.Lipoprotein (a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol, 1997; 17(11):2783–2792; doi: 10.1161/01.ATV.17.11.2783
46.
OrdovasJM, SchaeferEJ, SalemD, et al.Apolipoprotein AI gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med, 1986; 314(11):671–677; doi: 10.1056/NEJM198603133141102
47.
RanjithN, VerhoN, VerhoM, et al.Acute myocardial infarction in a young South African Indian-based population: Patient characteristics on admission and gender-specific risk factor prevalence. Curr Med Res Opin, 2002; 18(4):242–248; doi: 10.1185/030079902125000624
48.
SadeghianS, DarvishS, SalimiS, et al.Metabolic syndrome: Stronger association with coronary artery disease in young men in comparison with higher prevalence in young women. Coron Artery Dis, 2007; 18(3):163–168; doi: 10.1097/MCA.0b013e328012a94f
49.
SaleheenD, FrossardP. CAD risk factors and acute myocardial infarction in Pakistan. Acta Cardiol, 2004; 59(4):417–424; doi: 10.2143/AC.59.4.2005208
50.
TurhanH, YasarAS, BasarN, et al.High prevalence of metabolic syndrome among young women with premature coronary artery disease. Coron Artery Dis, 2005; 16(1):37–40; doi: 10.1097/00019501-200502000-00007
51.
VautrinE, JeanAEBP, FournyM, et al.Sex differences in coronary artery lesions and in-hospital outcomes for patients with ST-segment elevation myocardial infarction under the age of 45. Catheter Cardiovasc Interv, 2020; 96(6):1222–1230; doi: 10.1002/ccd.28627
52.
WesolowskaE, MarcilM, Lussier-CacanS, et al.Angiotensin converting enzyme insertion/deletion polymorphism in French Canadian subjects with premature coronary artery disease. Pathol Biol (Paris), 1998; 46(5):295–300; doi: 10.1002/ccd.28627
53.
YasarAS, TurhanH, BasarN, et al.Comparison of major coronary risk factors in female and male patients with premature coronary artery disease. Acta Cardiol, 2008; 63(1):19–25; doi: 10.2143/AC.63.1.2025327
54.
Kwiterovich Jr. PO, Coresh J, Smith HH, et al. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol, 1992; 69(12):1015–1021; doi: 10.1016/0002-9149(92)90856-t
55.
AlbertyR, StudenčanM, KovářF. Prevalence of conventional cardiovascular risk factors in patients with acute coronary syndromes in Slovakia. Cent Eur J Public Health, 2017; 25(1):77–84; doi: 10.21101/cejph.a4351
56.
AnderssonC, Lukács KrogagerM, Kuhr SkalsR, et al.Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizations. PLoS One, 2019; 14(2):e0211690; doi: 10.1371/journal.pone.0211690
57.
AroraS, StoufferGA, Kucharska-NewtonAM, et al.Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction: The ARIC Community Surveillance Study. Circulation, 2019; 139(8):1047–1056; doi: 10.1161/CIRCULATIONAHA.118.037137
58.
CaderFA, RahmanA, NasrinS, et al.Comparison of in-hospital outcomes of percutaneous coronary intervention between young male and female patients with acute coronary syndrome. Univ Heart J, 2016; 12(2):61–67; doi: 10.3329/uhj.v12i2.36385
59.
LanskyAJ, MehranR, DangasG, et al.Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. Am J Cardiol, 2004; 93(7):916–919; doi: 10.1016/j.amjcard.2003.12.046
60.
RicciB, CenkoE, VasiljevicZ, et al.Acute coronary syndrome: The risk to young women. J Am Heart Assoc, 2017; 6(12):e007519; doi: 10.1161/JAHA.117.007519
61.
Taylor-PiliaeRE, HaskellWL, IribarrenC, et al.Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J Cardiopulm Rehabil Prev, 2007; 27(4):227–232; doi: 10.1097/01.HCR.0000281768.97899.bb
62.
KanicV, KomparaG, VollrathM, et al.Sex-related anemia contributes to disparities in outcome of patients younger than 60 Years with ST-elevation myocardial infarction. J Womens Health (Larchmt), 2018; 27(6):755–760; doi: 10.1089/jwh.2017.6644
63.
IzadnegahdarM, SingerJ, LeeMK, et al.Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years. J Womens Health (Larchmt), 2014; 23(1):10–17; doi: 10.1089/jwh.2013.4507
64.
HahmannHW, Schätzer-KlotzD, BunteT, et al.The significance of high levels of lipoprotein (a) compared with established risk factors in premature coronary artery disease: Differences between men and women. Atherosclerosis, 1999; 144(1):221–228; doi: 10.1016/S0021-9150(99)00057-X
65.
PetrovičD, BregarD, Guzic-SalobirB, et al.Sex difference in the effect of ACE-DD genotype on the risk of premature myocardial infarction. Angiology, 2004; 55(2):155–158; doi: 10.1177/000331970405500207
66.
GlueckCJ, MunjalJ, AregawiD, et al.Thrombophilia–hypofibrinolysis and atherothrombotic cardiovascular disease ≤ age 45 years. Transl Res, 2007; 150(2):93–100; doi: 10.1016/j.trsl.2007.03.005
67.
ShahT, PalaskasN, AhmedA. An update on gender disparities in coronary heart disease care. Curr Atheroscler Rep, 2016; 18(5):28; doi: 10.1007/s11883-016-0574-5
68.
StoberockK, DebusES, AtlihanG, et al.Gender differences in patients with carotid stenosis. Vasa, 2016; 45(1):11–16; doi: 10.1024/0301-1526/a000490
69.
MadonnaR, BalistreriCR, De RosaS, et al.Impact of sex differences and diabetes on coronary atherosclerosis and ischemic heart disease. J Clin Med, 2019; 8(1):98; doi: 10.3390/jcm8010098
YiY, AnJ. Sex differences in risk factors for metabolic syndrome in the Korean population. Int J Environ Res Public Health, 2020; 17(24):9513; doi: 10.3390/ijerph17249513
72.
Regitz-ZagrosekV, LehmkuhlE, WeickertMO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardi, 2006; 95(3):147; doi: 10.1007/s00392-006-0351-5
73.
FezeuL, BalkauB, KengneA-P, et al.Metabolic syndrome in a sub-Saharan African setting: Central obesity may be the key determinant. Atherosclerosis, 2007; 193(1):70–76; doi: 10.1016/j.atherosclerosis.2006.08.037
PetrovM, MartinezSC, HolmvangL, et al.Peripheral arterial disease in women: An overview of risk factor profile, clinical features, and outcomes. Curr Atheroscler Rep, 2018; 20(8):40, doi: 10.1007/s11883-018-0742-x
76.
DiehmC, SchusterA, AllenbergJR, et al.High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study. Atherosclerosis, 2004; 172(1):95–105; doi: 10.1016/s0021-9150(03)00204-1
77.
ViraniSS, AlonsoA, AparicioHJ, et al.Heart disease and stroke statistics—2021 update: A report from the American Heart Association. Circulation, 2021; 143(8):e254–e743; doi: 10.1161/CIR.0000000000000950
78.
SunK, RenM, LiuD, et al.Alcohol consumption and risk of metabolic syndrome: A meta-analysis of prospective studies. Clin Nutr, 2014; 33(4):596–602; doi: 10.1016/j.clnu.2013.10.003
79.
YeomansMR. Alcohol, appetite and energy balance: Is alcohol intake a risk factor for obesity?. Physiol Behav, 2010; 100(1):82–89; doi: 10.1016/j.physbeh.2010.01.012
80.
BerlinI, LinS, LimaJA, et al.Smoking status and metabolic syndrome in the multi-ethnic study of atherosclerosis. A cross-sectional study. Tob Induc Dis, 2012; 10(1):9; doi: 10.1186/1617-9625-10-9
81.
DeFilippisEM, CollinsBL, SinghA, et al.Women who experience a myocardial infarction at a young age have worse outcomes compared with men: The Mass General Brigham YOUNG-MI registry. Eur Heart J, 2020; 41(42):4127–4137; doi: 10.1093/eurheartj/ehaa662
82.
LichtmanJH, LeifheitEC, SafdarB, et al.Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: Evidence from the VIRGO study (variation in recovery: Role of gender on outcomes of young AMI patients). Circulation, 2018; 137(8):781–790; doi: 10.1161/CIRCULATIONAHA.117.031650
83.
GiltayE, HoogeveenE, ElbersJ, et al.Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females. J Clin Endocrinol Metab, 1998; 83(2):550–553; doi: 10.1210/jcem.83.2.4574
84.
WooK, SandersonJ, SunY, et al.Hyperhomocyst (e) inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation, 2000; 101(12):e116; doi: 10.1161/01.cir.101.12.e116
85.
KhanSU, KhanMZ, SubramanianCR, et al.Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: A systematic review. JAMA Netw Open, 2020; 3(5):e205202; doi: 10.1001/jamanetworkopen.2020.5202
86.
FogacciF, GoriD, CiceroAF. Representativity of women and racial/ethnic minorities in randomized clinical trials on bempedoic acid: Positive efforts and lacking data. Eur J Intern Med, 2022; 96:122–123; doi: 10.1016/j.ejim.2021.11.006
87.
SimonySB, MortensenMB, LangstedA, et al.Sex differences of lipoprotein (a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study. Atherosclerosis, 2022; 355:76–82; doi: 10.1016/j.atherosclerosis.2022.06.1023
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
